| Tretinoin | Approved Investigational Nutraceutical | CD44 | 960 |
downregulated | Tretinoin results in decreased expression of CD44 mRNA alternative form | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | CD44 | 960 |
upregulated | Tretinoin results in increased expression of CD44 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | CD52 | 1043 |
upregulated | Tretinoin results in increased expression of CD52 mRNA | 1p36.11 | |
| Tretinoin | Approved Investigational Nutraceutical | CD53 | 963 |
upregulated | Tretinoin results in increased expression of CD53 mRNA | 1p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CD55 | 1604 |
upregulated | Tretinoin results in increased expression of CD55 mRNA | 1q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CD69 | 969 |
downregulated | Tretinoin results in decreased expression of CD69 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CD70 | 970 |
upregulated | Tretinoin results in increased expression of CD70 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CD9 | 928 |
downregulated | Tretinoin results in decreased expression of CD9 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CD9 | 928 |
upregulated | Tretinoin results in increased expression of CD9 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CDC20 | 991 |
downregulated | Tretinoin results in decreased expression of CDC20 mRNA | 1p34.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDC27 | 996 |
downregulated | Tretinoin results in decreased expression of CDC27 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | CDC42 | 998 |
downregulated | Tretinoin results in decreased expression of CDC42 mRNA | 1p36.12 | |
| Tretinoin | Approved Investigational Nutraceutical | CDC42EP3 | 10602 |
downregulated | Tretinoin results in decreased expression of CDC42EP3 mRNA | 2p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDC42EP3 | 10602 |
upregulated | Tretinoin results in increased expression of CDC42EP3 mRNA | 2p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDC45 | 8318 |
downregulated | Tretinoin results in decreased expression of CDC45 mRNA | 22q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | CDC6 | 990 |
downregulated | Tretinoin results in decreased expression of CDC6 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CDC7 | 8317 |
downregulated | Tretinoin results in decreased expression of CDC7 mRNA | 1p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CDCA3 | 83461 |
downregulated | Tretinoin results in decreased expression of CDCA3 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CDCA7 | 83879 |
downregulated | Tretinoin results in decreased expression of CDCA7 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CDCA7L | 55536 |
downregulated | Tretinoin results in decreased expression of CDCA7L mRNA | 7p15.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CDCA8 | 55143 |
downregulated | Tretinoin results in decreased expression of CDCA8 mRNA | 1p34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CDCP1 | 64866 |
upregulated | Tretinoin results in increased expression of CDCP1 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH1 | 999 |
downregulated | Tretinoin results in decreased expression of CDH1 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH1 | 999 |
upregulated | Tretinoin results in increased expression of CDH1 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CDH10 | 1008 |
downregulated | Tretinoin results in decreased expression of CDH10 mRNA | 5p14.2-p14.1 | |